|
||
J. Exp. Med.,
Volume 189, Number 7, April 5, 1999 1149-1156
By


From the * Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United
Kingdom; The nonclassical MHC class I molecule human histocompatibility leukocyte antigen (HLA)-G
is selectively expressed on fetal trophoblast tissue at the maternal-fetal interface in pregnancy. It
has long been suggested that HLA-G may inhibit maternal natural killer (NK) cells through interaction with particular NK cell receptors (KIRs). To investigate interactions of HLA-G, we constructed phycoerythrin-labeled tetrameric complexes of HLA-G refolded with a self-peptide.
These HLA-G tetramers failed to bind to NK cells and cells transfected with CD94/NKG2 and
killer immunoglobulin-like NK receptors. In contrast, HLA-G tetramers did bind to peripheral blood monocytes, staining a CD16+CD14mid subset with greater intensity. On transfectants,
HLA-G tetramers bound to inhibitory immunoglobulin-like transcript (ILT)2 and ILT4 receptors. However, staining in the presence of antibodies reactive with ILT receptors revealed that
the interaction of HLA-G tetramers with blood monocytes was largely due to binding to ILT4. These results suggest that the primary role of HLA-G may be the modulation of myelomonocytic cell behavior in pregnancy.
Basel Institute for Immunology, Basel CH-4005, Switzerland; § DNAX Research
Institute of Molecular and Cellular Biology, Palo Alto, California 94304; and the
Institute for
Animal Health, Compton RG20 7NN, United Kingdom
This article has been cited by other articles:
| TABLE OF CONTENTS |
|